You are here: Home » PTI Stories » National » News
Business Standard

Abbott India Q2 net profit up 23% at Rs 75 cr

Press Trust of India  |  New Delhi 

Pharma firm today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 61.16 crore in the year-ago period, said in a filing.



Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.

offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

of today closed 4.88 per cent higher at Rs 4,925 apiece on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Abbott India Q2 net profit up 23% at Rs 75 cr

Pharma firm Abbott India today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales. The company had posted a net profit of Rs 61.16 crore in the year-ago period, Abbott India said in a BSE filing. Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago. Abbott India offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. Shares of Abbott India today closed 4.88 per cent higher at Rs 4,925 apiece on BSE. Pharma firm today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 61.16 crore in the year-ago period, said in a filing.

Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.

offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

of today closed 4.88 per cent higher at Rs 4,925 apiece on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Abbott India Q2 net profit up 23% at Rs 75 cr

Pharma firm today reported a 22.66 per cent rise in standalone net profit at Rs 75.02 crore for the quarter ended September 30, mainly on account of robust sales.

The company had posted a net profit of Rs 61.16 crore in the year-ago period, said in a filing.

Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.

offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

of today closed 4.88 per cent higher at Rs 4,925 apiece on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard